The Director, Global IBD Portfolio and Growth Strategy is responsible for informing commercial prioritization of the company's IBD pipeline and product development priorities for pre-clinical and clinical-stage assets within the immunology portfolio.
Base: $190,800.00 - $300,300.00; Bonus/Equity: Annual bonus and long-term incentive, if applicable; Benefits: Comprehensive package of benefits
Must-have
Nice-to-have
Not specified